Literature DB >> 14569103

High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement.

Kerstin W A Westman1, Daina Selga, Per-Erik Isberg, Anna Bladström, Håkan Olsson.   

Abstract

Wegener granulomatosis (WG) and microscopic polyangiitis (MP), diseases associated with antineutrophil cytoplasmic antibodies (ANCA), had an extremely poor prognosis before the introduction of cyclophosphamide and corticosteroids for their treatment. However, there is still reduced patient survival, and some studies have documented severe side effects of the immunosuppressants used. This 10-yr follow-up study assessed 117 consecutive patients with WG or MP with biopsy-confirmed renal involvement. The cumulative relative patient survival was lower: 0.664 for women and 0.648 for men. The causes of death (n = 64) were in most cases registered as associated with the vasculitic disease. Analysis of possible predictive factors for patient survival by multiple Cox regression analysis revealed that a very high level of proteinase 3 (PR3)-ANCA measured by the capture ELISA method, a diagnosis of MP, and older age were factors predicting poorer patient survival. High levels of B-thrombocytes at time of diagnosis were associated with a better prognosis. For patients surviving the first year, remission-sustaining therapy with azathioprine for longer than 12 mo was associated with improved patient survival. Thirty-nine patients developed end-stage renal failure. Elevated serum creatinine at time of diagnosis and a very high level of PR3-ANCA by capture ELISA were factors predicting a higher risk for renal failure during follow-up. The epitope on PR3 assessed by capture ELISA needs to be further analyzed and explored: it seemed to implicate poorer patient and renal survival in WG or MP with renal involvement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569103     DOI: 10.1097/01.asn.0000093256.18266.22

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes.

Authors:  Lei Shi
Journal:  Rheumatol Int       Date:  2017-09-27       Impact factor: 2.631

Review 3.  Epidemiology of systemic vasculitis.

Authors:  Suzanne E Lane; Richard Watts; David G I Scott
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

4.  Outcome and treatment of elderly patients with ANCA-associated vasculitis.

Authors:  Maria Weiner; Su Mein Goh; Aladdin J Mohammad; Zdenka Hruskova; Anisha Tanna; Annette Bruchfeld; Daina Selga; Zdenka Chocova; Kerstin Westman; Per Eriksson; Charles D Pusey; Vladimir Tesar; Alan D Salama; Mårten Segelmark
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-22       Impact factor: 8.237

Review 5.  Renal involvement in Wegener's granulomatosis.

Authors:  Y Renaudineau; Y Le Meur
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 6.  Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.

Authors:  J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

7.  ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.

Authors:  Iuliana Andreiana; Simona Stancu; Andreea Avram; Ludmila Taran; Gabriel Mircescu
Journal:  BMC Nephrol       Date:  2015-06-30       Impact factor: 2.388

8.  Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement.

Authors:  Andreiana Iuliana; Stancu Simona; Avram Andreea; Taran Ludmila; Mircescu Gabriel
Journal:  J Med Life       Date:  2014

9.  ANCA-Positive Patients: The Influence of PR3 and MPO Antibodies on Survival Rate and The Association with Clinical and Laboratory Characteristics.

Authors:  J C Drooger; A Dees; A J G Swaak
Journal:  Open Rheumatol J       Date:  2009-03-04

10.  Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.

Authors:  Sophie Ohlsson; Omran Bakoush; Jan Tencer; Ole Torffvit; Mårten Segelmark
Journal:  Mediators Inflamm       Date:  2009-07-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.